FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

STAR

740.25
-12.3 (-1.63%)
Updated 03:28 28/07 IST

STAR Buy or Sell - FrontPage Forums

2 Users have submitted 2 trade ideas of Rs. 875,925 for STAR
Disclaimer
100% Bullish
0% Bearish

STAR Buy or Sell - Brokerage Reports

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
790
Consensus Potential
4.74%
See STAR Share Price Targets >>

STAR Ratings

Long term STAR rating by FrontPage users
5/5 (2 Ratings)
Find answers to all your questions on live STAR message board: Is STAR buy or sell? Should I buy STAR shares? Why are STAR shares falling? Should I invest in STAR stock?

  1. Home
  2. STAR Forum

STAR Share Price Discussion

N
Reputation: 15,707 • Today 4:06 AM
Dell tops most-desired brands list, shows report
There are 29 categories in the top-50 showing a diverse consumer choice. However, mobile phones are the most-desired category with nine entrants, followed by laptops and televisions (four brands each), he added.
The Economic Times
Like
Reply

Type
Buy
Instrument
STAR
Entry Price
₹780
Price@Trade
₹782.5
Target Price
₹900
Stop Price
₹720
Valid Till
Jul 26, 2022 3:20 AM
Margin
₹78,000 approx for 100 Qty
Status
Exited
Exit Price
₹771.7
Net P&L
-₹830 (-1.06%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 26 7:11 AM

Update
Trade Entered
Entry Price
₹780
Vaibhav Srivastav @vabsri
Yesterday 3:53 AM

Update
Exited
Exit Price
₹771.7
Net P&L
-₹830 (-1.06%)
N
Reputation: 15,707 • Jul 24 11:41 AM
Xi Jinping meets top military officials in Lhasa; highlights lasting stability and prosperity in Tibet
Xi, also General Secretary of the ruling Communist Party of China (CPC) and Chairman of the Central Military Commission, met top officials of the Tibet Military Command of the People's Liberation Army, guarding China's border with India in Arunachal Pradesh.
The Economic Times
Like
Reply
Login • Instagram
Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.
www.instagram.com
Like
Reply
N
Reputation: 15,707 • Jul 21 7:26 AM
China stocks rise, Shenzhen's start-up board hits 6-year high
The blue-chip CSI300 index rose 0.7% to 5,144.04 points, while the Shanghai Composite Index gained 0.7% to 3,562.66 points.
The Economic Times
Like
Reply

Type
Buy
Instrument
STAR
Entry Price
₹785
Price@Trade
₹785
Target Price
₹880
Stop Price
₹700
Valid Till
Jul 19, 2022 3:20 AM
Margin
₹98,125 approx for 125 Qty
Status
Active

Like
Reply
swap_vert
Trade
A
Reputation: 1,296 • Jul 18 2:57 AM

CMP 789
TARGET 845-945
TIME SPAN: 6 WEEKS
Like
Reply
N
Reputation: 15,707 • Jul 16 9:06 AM
Adityanath govt turned UP into one of 'leading states' in country, claims Nadda
Nadda said four years ago the state was "afflicted by appeasement politics" where a particular caste used to get benefits and the other faced harassment.
The Economic Times
Like
Reply
N
Reputation: 15,707 • Jul 15 1:01 AM
KKR completes stake buy in Vini Cosmetics for Rs 4,600 crore
In June this year, KKR had announced that it is paying USD 625 million or Rs 4,600 crore for a majority stake in the 11-year-old Vini, which manufactures and markets brands like Fogg.
The Economic Times
Like
Reply

#ASTRAL and #STAR will be added to F&O segment effective July 30
Like
Reply
K
Reputation: 15,044 • Jul 13 8:57 AM
4
Reply
N
Reputation: 15,707 • Jul 7 11:06 AM
COVID-19: Detected across 30 countries, Lambda variant 'deadlier' than Delta
Lambda accounts for nearly 82 percent of the coronavirus case samples reported during May and June in Peru, Euro News reported citing the Pan American Health Organisation (PAHO).
The Economic Times
Like
Reply
N
Reputation: 15,707 • Jul 4 4:41 AM
View: How Yogi Adityanath created a strong foundation for a better future in Uttar Pradesh
According to the Centre for Monitoring Indian Economy (CMIE), UPs unemployment rate now stands at 6.9%, one of the lowest in the country, down from above 18% in 2017. The gross enrolment rate in higher education in the 18-23 age group has gone up to the national average, and today UP has the largest number of students.
The Economic Times
Like
Reply
N
Reputation: 15,707 • Jul 1 7:01 AM
Data, demographic dividend present huge opportunity; this decade to be 'India's techade': PM
Digital solutions created by India during COVID-19 pandemic are being acknowledged globally, PM Modi said adding that contact tracing app, Aarogya Setu, has played a key role in containing the spread of COVID-19 in the country.
The Economic Times
Like
Reply
N
Reputation: 15,707 • Jul 1 4:21 AM
India's strides in medicine have contributed to make planet healthier: PM on Doctors' Day
"We are all grateful for the contribution of doctors in the Corona period. Our doctors have served us without caring about their lives. Therefore, this time National Doctors' Day becomes all the more special," Modi had said in his radio broadcast.
The Economic Times
Like
Reply
N
Reputation: 15,707 • Jun 28 6:26 AM
Strides Pharma Science's Puducherry facility successfully completes EU GMP inspection
The inspection was carried out on April 28, 2021 and the company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection, Strides Pharma Science said in a regulatory filing.
The Economic Times
Like
Reply

Strides Pharma ; Strides announces successful completion of EU GMP inspection at Puducherry facility. Facility maintains continued GMP compliance status
Like
Reply
Like
Reply

Buy star (stride pharma) at 783 sl 740 target 950+
Like
Reply
H
Reputation: 5,535 • Jun 21 8:20 AM

Type
Buy
Instrument
STAR
Entry Price
₹775
Price@Trade
₹775
Target Price
₹820
Stop Price
₹750
Valid Till
Jul 20, 2021 3:20 AM
Margin
₹77,500 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹750
Net P&L
-₹2,500 (-3.23%)

Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jun 22 2:46 AM

Update
Stoploss Hit
Exit Price
₹750
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • STAR - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization4,223.63
    Enterprise Value4,851.82
    Price to Earnings6.74
    Price to Book Value1.3
    Return on Capital Employed0.26
    Return on Equity0.28
    Face Value10
    Dividend YieldNA
  • STAR - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    30-Oct-20Motilal OswalBuy790
    17-Mar-20Geojit Financial ServicesHold357
    11-Dec-19Motilal OswalBuy440
    5-Jul-19ICICIdirect.comBuy472
    15-May-19Geojit Financial ServicesReduce401
    STAR Brokerage Price Target
  • STAR Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 28756759734739.55
    Jul 27772777.2748.3752.55
    Jul 26766789.4762.9769.8
    Jul 23778778765.5768.5
    Jul 22770781765.1776.55
  • STAR Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹775.79
    30 Day Moving Average₹775.26
    50 Day Moving Average₹783.85
    100 Day Moving Average₹816.09
    200 Day Moving Average₹808.96
  • STAR - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,4702,109.8-0.3
    Operating Profit164186.99-0.12
    Profit Before Tax899123.96.26
    Net Income892108.547.22
  • STAR - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,2573,1620.03
    Total Liabilities1,4061,1690.2
    Total Assets4,6634,3310.08
  • STAR - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity66411.74-0.84
    Cash from Investing Activity433-882.82-1.49
    Cash from Financing Activity-707-67.249.51
    Net Cash Flow-208-538.32-0.61
  • STAR - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.210.02
    Return on Equity0.280.03
    Return on Capital Employed0.260.05
  • STAR - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.58
    3 Year CAGR Growth in Operating Profit0.44
    3 Year CAGR Growth in EBIDTA0.41
    3 Year CAGR Growth in Net Income0.68
    3 Yr CAGR Growth - Diluted EPS0.12
  • STAR - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.06
    5 Year CAGR Growth in Operating Profit4.28
    5 Year CAGR Growth in EBIDTA6.06
    5 Year CAGR Growth in Net Income14.93
    3 Yr CAGR Growth - Diluted EPS9.47
  • STAR - Recent News

    keyboard_arrow_down
    NewsBot
    Today 4:06 AM
    Dell tops most-desired brands list, shows report
    The Economic Times
    NewsBot
    Jul 24 11:41 AM
    Xi Jinping meets top military officials in Lhasa; highlights lasting stability and prosperity in Tibet
    The Economic Times
    NewsBot
    Jul 21 7:26 AM
    China stocks rise, Shenzhen's start-up board hits 6-year high
    The Economic Times
    NewsBot
    Jul 16 9:06 AM
    Adityanath govt turned UP into one of 'leading states' in country, claims Nadda
    The Economic Times
    NewsBot
    Jul 15 1:01 AM
    KKR completes stake buy in Vini Cosmetics for Rs 4,600 crore
    The Economic Times
    NewsBot
    Jul 7 11:06 AM
    COVID-19: Detected across 30 countries, Lambda variant 'deadlier' than Delta
    The Economic Times
    NewsBot
    Jul 4 4:41 AM
    View: How Yogi Adityanath created a strong foundation for a better future in Uttar Pradesh
    The Economic Times
    NewsBot
    Jul 1 7:01 AM
    Data, demographic dividend present huge opportunity; this decade to be 'India's techade': PM
    The Economic Times
    NewsBot
    Jul 1 4:21 AM
    India's strides in medicine have contributed to make planet healthier: PM on Doctors' Day
    The Economic Times
    NewsBot
    Jun 28 6:26 AM
    Strides Pharma Science's Puducherry facility successfully completes EU GMP inspection
    The Economic Times
  • STAR - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020